Neuren Pharmaceuticals Limited Stock Filter Stocks by Fundamentals
| NURPF Stock | USD 12.53 0.00 0.00% |
Neuren Pharmaceuticals Limited fundamentals help investors to digest information that contributes to Neuren Pharmaceuticals' financial success or failures. It also enables traders to predict the movement of Neuren Pink Sheet. The fundamental analysis module provides a way to measure Neuren Pharmaceuticals' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Neuren Pharmaceuticals pink sheet.
Neuren |
Did you try this?
Run Idea Analyzer Now
Idea AnalyzerAnalyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas |
| All Next | Launch Module |
Neuren Fundamentals
| Return On Equity | -0.27 | |||
| Return On Asset | -0.17 | |||
| Profit Margin | (2.15) % | |||
| Operating Margin | (2.31) % | |||
| Current Valuation | 602.02 M | |||
| Shares Outstanding | 128.97 M | |||
| Shares Owned By Insiders | 16.48 % | |||
| Shares Owned By Institutions | 9.41 % | |||
| Price To Earning | 49.75 X | |||
| Price To Book | 27.96 X | |||
| Price To Sales | 203.95 X | |||
| Revenue | 3.2 M | |||
| Gross Profit | (6.32 M) | |||
| EBITDA | (11.43 M) | |||
| Net Income | (7.79 M) | |||
| Cash And Equivalents | 31.09 M | |||
| Cash Per Share | 0.25 X | |||
| Current Ratio | 31.54 X | |||
| Book Value Per Share | 0.27 X | |||
| Cash Flow From Operations | (9.97 M) | |||
| Earnings Per Share | (0.05) X | |||
| Number Of Employees | 15 | |||
| Beta | 1.5 | |||
| Market Capitalization | 660.11 M | |||
| Total Asset | 40.06 M | |||
| Retained Earnings | (97 M) | |||
| Working Capital | 7 M | |||
| Current Asset | 9 M | |||
| Current Liabilities | 2 M | |||
| Z Score | -2.8 | |||
| Net Asset | 40.06 M |
About Neuren Pharmaceuticals Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Neuren Pharmaceuticals Limited's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Neuren Pharmaceuticals using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Neuren Pharmaceuticals Limited based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Neuren Pharmaceuticals in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Neuren Pharmaceuticals' short interest history, or implied volatility extrapolated from Neuren Pharmaceuticals options trading.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Neuren Pharmaceuticals Limited. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in american community survey. You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Complementary Tools for Neuren Pink Sheet analysis
When running Neuren Pharmaceuticals' price analysis, check to measure Neuren Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Neuren Pharmaceuticals is operating at the current time. Most of Neuren Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Neuren Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Neuren Pharmaceuticals' price. Additionally, you may evaluate how the addition of Neuren Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
| Stocks Directory Find actively traded stocks across global markets | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| AI Investment Finder Use AI to screen and filter profitable investment opportunities | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets |